CHLD
CHANGE OF OWNER RECEIVED FROM IB
19/11/2023
Voltar para busca
Dado oficial do USPTO
MACFARLAN SMITH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
19/11/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 40, 42
Data de depósito
21/06/2007
Data de registro
30/06/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2020
Última transação
18/02/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
GB
Examinador
PERKINS, ELLEN
Unidade examinadora
M10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Macfarlan Smith Limited
Johnson Matthey Public Limited Company
Representantes
A TALLY EITAN Eitan Mehulal Sadot
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical compounds for use in the manufacture of pharmaceuticals; chemicals for use as active pharmaceutical ingredients; chemical preparations and substances used to denaturise other chemical substances by rendering them unsuitable for human and animal consumption
Classe 5
Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use as pain relief medication; pharmaceutical preparationsopiates and opioids
Classe 40
Custom manufacture of pharmaceuticals and active pharmaceutical ingredients
Classe 42
Research and development of pharmaceuticals and active pharmaceutical ingredients
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/02/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
18/02/2020
71AG
REGISTERED-SEC.71 ACCEPTED
18/02/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
18/02/2020
PR71
POST REGISTRATION ACTION MAILED - SEC.71
13/02/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/02/2020
PR71
POST REGISTRATION ACTION MAILED - SEC.71
09/09/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2019
ES71
TEAS SECTION 71 RECEIVED
25/06/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
30/06/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/08/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/06/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
15/11/2016
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
15/11/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/11/2016
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
22/07/2016
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
28/01/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/01/2016
ES75
TEAS SECTION 71 & 15 RECEIVED
21/12/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/01/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/10/2009
FIMP
FINAL DISPOSITION PROCESSED
07/10/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/09/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2009
PUBO
PUBLISHED FOR OPPOSITION
14/04/2009
NPUB
NOTICE OF PUBLICATION
25/03/2009
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/03/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/03/2009
ALIE
ASSIGNED TO LIE
06/03/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/03/2009
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/02/2009
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/02/2009
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/09/2008
GNFR
FINAL REFUSAL E-MAILED
10/09/2008
CNFR
FINAL REFUSAL WRITTEN
10/09/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/08/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/08/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/08/2008
DOCK
ASSIGNED TO EXAMINER
05/05/2008
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
11/03/2008
GPRA
PRIORITY ACTION E-MAILED
11/03/2008
CPRA
PRIORITY ACTION WRITTEN
11/03/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/12/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/12/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/12/2007
RFNP
REFUSAL PROCESSED BY IB
26/10/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/10/2007
RFRR
REFUSAL PROCESSED BY MPU
02/10/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/10/2007
CNRT
NON-FINAL ACTION WRITTEN
01/10/2007
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
25/09/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/09/2007
CNRT
NON-FINAL ACTION WRITTEN
24/09/2007
DOCK
ASSIGNED TO EXAMINER
24/09/2007
NWAP
NEW APPLICATION ENTERED
21/09/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/09/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MACFARLAN SMITH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.